ABSTRACT
A licensing agreement for the further development and commercialization of the product has been signed between the CSIR, a research institute in South Africa, and Phytopharm plc, which specializes in the development of phytomedicines. The CSIR is one of the largest scientific and technological research organizations in Africa, employing approximately 3300 staff and currently performing about 12 per cent of all the industrial research and development on the continent. Some 40 per cent of its income is derived from the government, and the remaining 60 per cent from contract research work for its clients.
